Skip to content

Eikon Therapeutics, Inc. EIKN Finance Lease Liabilities (Total)

Finance Lease Liabilities (Total) at other companies

MYR Group logo
MYR GroupMYRG
$1.8M-33.0%
Travel + Leisure logo
Travel + LeisureTNL
$18M-5.3%
Warrior Met Coal logo
Warrior Met CoalHCC
$79.56M+329%
SSR Mining logo
SSR MiningSSRM
$83.1M-3.6%
Atmus Filtration Technologies logo
Atmus Filtration TechnologiesATMU
$2.1M+40.0%
LKQ logo
LKQLKQ
$101M-4.7%

Other financials

Income statement

See full
Operating income-$87.3M-22.3%
Net income-$83.0M-21.6%
EPS (diluted)-$2.46+90.9%

Balance sheet

See full
Cash & equivalents$161.2M-21.2%
Total debt$254.8M
Total equity$550.7M+186%
Total assets$850.8M

Cash flow

See full
Operating cash flow-$89.8M-64.7%
CapEx$262.0K-98.8%
Free cash flow-$90.1M-17.1%

Valuation

See full
Market cap$521.35M

Where this comes from

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eikon Therapeutics, Inc. 's finance lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eikon Therapeutics, Inc. 's finance lease liabilities (total)?
Eikon Therapeutics, Inc. (EIKN) reported finance lease liabilities (total) of $0 in Q1 2026.
What does finance lease liabilities (total) mean?
Finance lease liabilities (total) represent the aggregate present value of all future lease payments for assets where the company assumes substantially all risks and rewards of ownership. This metric reflects the long-term debt-like burden associated with financing infrastructure or equipment through leases. It is a key component of the company's total leverage profile.